CD86 and COVID-19: Immunophenotyping of blood myeloid leukocytes in COVID‐19 inpatients and healthy control reveals four patterns of innate response involving nonclassical monocytes, CD86, CD163, CD40 and ferroportin (FPN1) surface expression in monocytes and neutrophil levels.